TransCode Therapeutics (RNAZ) Prices 21.22M Share Offering at $0.377/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. WDC
2. DECK
3. RNG
4. BYD
5. WCN
6. SPOT
7. FIX
8. BE
9. BMY
10. NDAQ

Go back to TransCode Therapeutics (RNAZ) Prices 21.22M Share Offering at $0.377/sh

TransCode Therapeutics, Inc. Announces $8 Million Private Placement

November 27, 2024 7:00 AM EST

BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA Oncology Company committed to more effectively treating cancer using RNA therapeutics, today announced that it has entered into a securities purchase agreement with certain institutional investors. The aggregate gross cash proceeds are expected to be approximately $8 million before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the private placement for general corporate purposes and working capital.

In connection with the private... More